Gumbohatch
avian infectious bursal disease vaccine (live)
Table of contents
Overview
Gumbohatch is a vaccine used to protect broiler chickens (reared for meat) against infectious bursal disease (IBD) virus infection caused by a very virulent IBD virus. Virulent means that the virus is capable of producing severe disease.
IBD, also known as Gumboro disease, is a highly contagious (spreads easily) viral infection of young chickens that reduces their immunity (body’s ability to fight disease) and can lead to their death at 3 to 6 weeks of age. Signs of chickens infected with Gumboro disease include trembling, ruffled feathers, poor appetite, dehydration, diarrhoea, huddling and depression. The vaccine reduces signs of the disease and damage to the bursa of Fabricius, an organ only present in birds which is part of their immune system.
Gumbohatch contains a live strain of IBD virus (strain 1052) that has been weakened so that it does not cause the disease.
Authorisation details
Product details | |
---|---|
Name |
Gumbohatch
|
Agency product number |
EMEA/V/C/004967
|
Active substance |
live attenuated infectious bursal disease virus (IBDV), strain 1052
|
International non-proprietary name (INN) or common name |
avian infectious bursal disease vaccine (live)
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI01AD09
|
Publication details | |
---|---|
Marketing-authorisation holder |
Laboratorios Hipra, S.A.
|
Revision |
2
|
Date of issue of marketing authorisation valid throughout the European Union |
12/11/2019
|
Contact address |
Avda. La Selva 135 |
Product information
20/01/2021 Gumbohatch - EMEA/V/C/004967 - II/0004
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Immunologicals for aves
-
Domestic fowl
-
Live viral vaccines
-
avian infectious bursal disease virus (gumboro disease)
Therapeutic indication
For active immunisation of 1-day-old broiler chicks and embryonated broiler chicken eggs to reduce clinical signs and lesions of the bursa of Fabricius caused by very virulent avian infectious bursal disease virus infection.